Population
Hypertensive adults (18 years and older) in developing countries. 42 studies across 19 developing countries.
Design
Systematic_review
Authors
Loading...
High non-adherence prevalence warrants routine clinical adherence support; confirms barriers as priorities for targeted research.
Medication non-adherence to antihypertensive treatment is highly prevalent (47.34%) in developing countries and is driven by socioeconomic, perceptual, and health system barriers.
Dhar et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: